A Long-term Extension Study of Ustekinumab in Pediatric Participants

NCT05092269 · clinicaltrials.gov ↗

PHASE3

Phase

ACTIVE_NOT_RECRUITING

Status

159

Enrollment

INDUSTRY

Sponsor class

Conditions

Crohn Disease
Colitis, Ulcerative
Arthritis, Psoriatic

Interventions

DRUG: Ustekinumab

Sponsor

Janssen Research & Development, LLC